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Left ventricular remodeling and hypertrophy in
patients with aortic stenosis: insights from
cardiovascular magnetic resonance
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Alicia Maceira1, Isabelle Roussin1, David B Northridge2, Philip J Kilner1,3, Stuart A Cook1,3, Nicholas A Boon2,
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Abstract
Background: Cardiovascular magnetic resonance (CMR) is the gold standard non-invasive method for determining
left ventricular (LV) mass and volume but has not been used previously to characterise the LV remodeling response
in aortic stenosis. We sought to investigate the degree and patterns of hypertrophy in aortic stenosis using CMR.
Methods: Patients with moderate or severe aortic stenosis, normal coronary arteries and no other significant valve
lesions or cardiomyopathy were scanned by CMR with valve severity assessed by planimetry and velocity mapping.
The extent and patterns of hypertrophy were investigated using measurements of the LV mass index, indexed LV
volumes and the LV mass/volume ratio. Asymmetric forms of remodeling and hypertrophy were defined by a
regional wall thickening ≥13 mm and >1.5-fold the thickness of the opposing myocardial segment.
Results: Ninety-one patients (61±21 years; 57 male) with aortic stenosis (aortic valve area 0.93±0.32cm2) were
recruited. The severity of aortic stenosis was unrelated to the degree (r2=0.012, P=0.43) and pattern (P=0.22) of
hypertrophy. By univariate analysis, only male sex demonstrated an association with LV mass index (P=0.02). Six
patterns of LV adaption were observed: normal ventricular geometry (n=11), concentric remodeling (n=11),
asymmetric remodeling (n=11), concentric hypertrophy (n=34), asymmetric hypertrophy (n=14) and LV
decompensation (n=10). Asymmetric patterns displayed considerable overlap in appearances (wall thickness 17
±2mm) with hypertrophic cardiomyopathy.
Conclusions: We have demonstrated that in patients with moderate and severe aortic stenosis, the pattern of LV
adaption and degree of hypertrophy do not closely correlate with the severity of valve narrowing and that
asymmetric patterns of wall thickening are common.
Trial registration: ClinicalTrials.gov Reference Number: NCT00930735
Keywords: Aortic valve disease, MRI, Cardiac remodeling
Background
Aortic stenosis is characterised by progressive narrowing
of the aortic valve and can be considered the paradigm
for left ventricular pressure overload. The ventricle
responds to this pressure overload by triggering a hyper-
trophic response, leading to an increase in myocyte size,
left ventricular wall thickness and mass. Initially this
response restores wall stress [1,2] but ultimately proves
maladaptive and predicts an adverse prognosis both in
the context of hypertension and aortic stenosis [3-5].
There is wide individual variation in both the degree
and pattern of hypertrophy observed in aortic stenosis.
Indeed, four patterns of anatomic adaption have been
described in response to an increased afterload on the
basis of echocardiographic measurements of left ven-
tricular mass, volumes and the relative wall thickness
[6,7]. These patterns are: normal ventricular geometry,
concentric remodeling, concentric hypertrophy, and
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eccentric hypertrophy. Asymmetric patterns have also
been reported [8,9], however these have not been
included in the above or other definitions.
The assessment of left ventricular remodeling and
hypertrophy by echocardiography has several limitations
when compared to cardiovascular magnetic resonance
(CMR). This latter technique offers the more precise mea-
surements of left ventricular mass, volume and wall thick-
ness [10,11] but has not previously been used to
characterise the hypertrophic response of the left ventricle
in aortic stenosis. The aim of this study was to use CMR
to investigate both the different morphological patterns of
LV adaption observed in this condition and the factors
affecting the magnitude of the hypertrophic response.
Methods
Patients with aortic stenosis
Patients referred to the Royal Brompton Hospital CMR
Unit between January 2003 and November 2009 with
moderate or severe aortic stenosis on their most recent
echocardiogram (peak velocity >3 m/s, aortic valve area
<1.5 cm2) were studied. In our institution, local guide-
lines recommend CMR for all patients with severe aortic
stenosis. Other reasons for referral included diagnostic
evaluation, clarification of disease severity, pre-operative
evaluation, and assessment of the hypertrophic response.
In order to study the effects of aortic stenosis on the
ventricle in isolation, our cohort was carefully selected
to avoid patients with confounding drivers of left ven-
tricular remodeling. Exclusion criteria therefore included
those with prior myocardial infarction, uncontrolled
hypertension (>180/120 mmHg), significant valve dis-
ease other than aortic stenosis (moderate or severe mi-
tral, tricuspid or pulmonary valve disease and moderate
or severe aortic regurgitation), a clinical diagnosis of
co-existent cardiomyopathy including hypertrophic car-
diomyopathy, amyloidosis, disseminated malignancy and
severe renal failure (estimated glomerular filtration rate
<30 mL/min). Coronary artery disease was excluded by
invasive coronary angiography (84% of the cohort), mul-
tidetector computed tomography coronary angiography
(8%) or stress perfusion imaging (2%). In patients under
40 years, it was excluded in the absence of symptoms or
risk factors (6%). Comprehensive baseline clinical char-
acteristics and history were obtained using a standar-
dised structured proforma and were completed from
source clinic record data and patient questionnaires.
The study was conducted with the patient’s consent,
local research ethics committee approval and in accord-
ance with the declaration of Helsinki.
CMR protocol
CMR was performed on Avanto 1.5 T magnetic reson-
ance scanners (Siemens, Erlangen, Germany) using
steady-state free precession sequences for the assess-
ment of left ventricular volumes and mass. Aortic valve
stenosis severity was assessed by echocardiography and
confirmed by CMR using a combination of peak velocity
and planimetry of the aortic valve area [12]. For quan-
tification of left ventricular function and volumes, en-
docardial and epicardial contours were identified in
end-diastole and end-systole, and planimetry performed
with dedicated semi-automated analysis software (CMR
Tools, Cardiovascular Imaging Solutions, London, UK).
The left ventricular mass was calculated from the total
myocardial volume multiplied by the specific gravity of
the myocardium (1.05 g/mL), with trabeculations and
papillary muscles included. The left ventricular mass and
volumes (end-diastolic and end-systolic) were indexed to
body surface area (calculated using the Mosteller for-
mula) to provide the LV mass index and indexed vol-
umes. Left ventricular dilatation and hypertrophy were
defined as an indexed left ventricular end-diastolic vol-
ume (LVEDV) and mass >95th percentile of the widely-
used normal range, published by Maceira et al, corrected
for age and gender [13]. Similarly left ventricular ejec-
tion fraction was reduced if below the 95th percentile
[13]. The maximal wall thickness was measured by
blinded observers from the short-axis views of the left
ventricle in end diastole, and its position with reference
to the 17-segment model of the left ventricle recorded
[14]. Right and left ventricular trabeculations were ex-
cluded from wall thickness measurements. Asymmetric
left ventricular wall thickening was defined as a regional
wall thickening ≥13 mm that was also >1.5-fold the
thickness of the opposing myocardial segment. Criteria
had to be fulfilled on two adjacent short-axis slices.
The LV mass/volume ratio (M/V)
The LV mass/volume ratio (M/V) is calculated by divid-
ing the left ventricular mass by the left ventricular end
diastolic volume [15-17]. It indexes wall thickness to cav-
ity size and is therefore the conceptual equivalent of the
echocardiogram-derived relative wall thickness (twice the
posterior wall thickness divided by the LV end-diastolic
diameter). However, because M/V lacks a well-defined
normal reference range, age and sex-matched healthy
volunteers without co-existent coronary artery disease,
hypertension, aortic stenosis or other forms of heart dis-
ease were recruited and scanned contemporaneously.
The normal range calculated from this cohort was then
applied to the patients with aortic stenosis.
Definition of the patterns of left ventricular hypertrophy
and remodeling
Aortic stenosis patients were categorised into six, pre-
defined patterns of left ventricular anatomic adaption
according to the LV mass index, the indexed LVEDV
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and M/V as follows. Normal ventricular structure:
characterised by a normal M/V, normal LV mass index
and normal indexed LVEDV. Concentric remodeling:
characterised by an increased M/V but normal LV mass
index. Asymmetric remodeling: similar to concentric
remodeling but with evidence of asymmetric wall thick-
ening. Concentric Hypertrophy: characterised by an
increased M/V and LV mass index. Asymmetric hy-
pertrophy: similar to concentric hypertrophy but with
evidence of asymmetric wall thickening. Eccentric
hypertrophy: characterised by an increased LV mass
index, a dilated left ventricle, normal M/V and a normal
ejection fraction (Figure 1).
Statistical analysis
Continuous variables were expressed as mean ± standard
deviation, and compared using unpaired Student’s t-test
or one-way analysis of variance where appropriate. Cat-
egorical variables were expressed as percentages and
analyzed using the chi-squared test or Fisher’s exact test
as appropriate. Statistical significance was defined as
two-sided P< 0.05. Correlation between normally dis-
tributed data was performed using Pearson’s correlation
to provide r2 values. Univariate analysis was performed
to determine independent predictors of LV mass index.
Further sub-group analyses were performed in patients
with and without concomitant hypertension, and
Figure 1 CMR definitions of the six patterns of left ventricular hypertrophy and remodeling in aortic stenosis. Schematic representation
of the left ventricular structure alongside CMR short-axis images of the left ventricle in end-diastole. Normal ventricular structure: characterised
by a normal LV mass index, indexed LVEDV, and a normal M/V. Concentric remodeling: characterised by an increased M/V and normal LV mass
index. Asymmetric remodeling: similar to concentric remodeling except that in addition there is evidence of asymmetric wall thickening.
Concentric Hypertrophy: characterised by an increased M/V and LV mass index. Asymmetric hypertrophy: similar to concentric hypertrophy
except that in addition there is evidence of asymmetric wall thickening. Left Ventricular Decompensation: characterised by a dilated left
ventricle and normal M/V. The LV mass index may be increased primarily due to LV dilatation. Note no patients fulfilled the criteria for eccentric
hypertrophy and so this was replaced by LV decompensation. ↑increased; ↓decreased; = normal; ✓present; ✖absent.
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according to sex. All statistical analysis was performed
using Stata 10.1 software (StataCorp, Texas, USA).
Results
Study population
Ninety-one patients (61 ± 21 years; 57 male; 37 with a
history of hypertension) were assessed and had moderate
(31%) or severe (69%) aortic stenosis and a mean aortic
valve area (AVA) of 0.93 ± 0.32 cm2 (Table 1). Ninety-
one healthy control subjects were identified and
matched to the aortic stenosis cohort for age and sex
(mean age 61 ± 10 years, 61% male). M/V in this group
was 0.88 ± 0.14 g/mL (95% confidence intervals: 0.60 to
1.16), consistent with previous studies [16]. There was
no correlation between M/V values and age (r2 = 0.04,
P = 0.073). The M/V was subsequently calculated for
each patient with aortic stenosis and values above
1.16 g/mL were considered elevated.
Determinants of left ventricular hypertrophy
The LV mass index was unrelated to aortic stenosis se-
verity both in terms of the aortic valve area (r2 = 0.012
P = 0.43, Figure 2) and the aortic valve area indexed to
body surface area (r2 = 0.002, P = 0.67). There was no dif-
ference in the degree of hypertrophy between patients
with moderate and severe disease (mean difference in
mass 3.9 g/m2, 95% CI -7.6 to 15.5 g/m2, P = 0.50). The
lack of correlation between aortic stenosis severity
(AVA) and the LV mass index persisted in sub-group
analyses of sex (male: r2 = 0.000, P = 0.91; female:
r2 = 0.020, P = 0.44) and after excluding those with hyper-
tension (r2 = 0.003, P = 0.62; Figure 2).
After univariate analysis, male sex was the only vari-
able associated with an increased LV mass index, being
13.8 g/m2 (95% CI, 2.8 to 24.7 g/m2, P = 0.02) higher in
men (Table 2) with an apparent trend to an increased
mass with co-existent hypertension (mean difference
9.9 g/m2; 95% CI, -1.1 to 20.9 g/m2, P = 0.08).
Left ventricular characteristics of patients with aortic
stenosis
Twelve per cent (n = 11) of subjects had normal left ven-
tricular structure and 24% left ventricular remodeling
(n = 22;11asymmetricand11concentric)(Table1,Figure1).
Left ventricular hypertrophy was the most prevalent pat-
tern and occurred in 53% (n = 48) of subjects (concentric
71%; asymmetric 29%). Absolute wall thickness was simi-
lar between patients with remodeling and hypertrophy
(15 ± 3 vs 16 ± 2 mm; P = 0.16) but the indexed mass was
significantly higher in those with hypertrophy (112 ± 22 vs
Table 1 Characteristics of patients with different forms of remodeling and hypertrophy
Normal
ventricle
Concentric
remodeling
Asymmetric
remodeling
Concentric
hypertrophy
Asymmetric
hypertrophy
LV
decompensation
P value
Number 11 11 11 34 14 10 -
Male sex (%) 45 55 82 65 64 60 0.62
Age (years) 52 ± 26 54 ± 21 70 ± 12 57 ± 18 75 ± 11 69 ± 18 0.01*
CMR DATA
Indexed LVEDV (mL/m2) 76 ± 9 55 ± 12 56 ± 9 77± 19 78 ± 24 126 ± 34 <0.01*
LV mass index (g/m2) 63 ± 11 75 ± 10 78 ± 7 113± 21 110 ± 24 106 ± 18 <0.01*
M/V (g/mL) 0.84 ± 0.16 1.39 ± 0.31 1.43 ± 0.28 1.51 ± 0.28 1.47 ± 0.33 0.88 ± 0.19 <0.01*
Maximal wall
thickness (mm)
11 ± 2 13± 3 17± 2 15± 2 17± 2 13± 2 <0.01*
Ejection Fraction (%) 73 ± 5 77 ± 9 76± 15 70 ± 13 67 ± 14 45 ± 16 <0.01*
Impaired Ejection
Fraction (%)
0 0 0 15 14 100 <0.01*
Aortic valve area (cm2) 0.85 ± 0.30 0.90 ± 0.43 1.10 ± 0.32 0.98 ± 0.34 0.86 ± 0.25 0.80 ± 0.16 0.22
Peak Velocity (m/s) 3.6 ± 0.4 3.6 ± 0.8 3.42 ± 0.67 4.0 ± 0.97 3.80 ± 0.76 3.8 ± 0.8 0.17
Severe AS (%) 73 64 45 65 78 100 0.13
CLINICAL DATA
Bicuspid valve (%) 55 45 27 41 29 40 0.76
Hypertension (%) 9 18 64 38 64 50 0.03*
Diabetes Mellitus (%) 18 0 18 15 7 30 0.45
ACEi/ARB (%) 20 10 55 39 36 22 0.18
Beta blocker (%) 20 10 37 18 18 20 0.56
Demographic, CMR and clinical data for patients with normal LV structure, concentric remodeling, asymmetric remodeling, concentric hypertrophy, asymmetric
hypertrophy and LV decompensation.
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76 ± 9 g/m2; P< 0.001) and the LVEDV lower in those with
remodeling (78 ± 20 vs 56 ± 10 ml/m2; P< 0.001). In the
majority of patients with hypertrophy, left ventricular ejec-
tion fraction was preserved but it was impaired in 7 sub-
jects (mean ejection fraction of 48%). No patient met the
pre-defined criteria for eccentric hypertrophy. However,
10 patients (11%), all with severe AS, were observed to
have a dilated left ventricle, increased indexed mass and
normal M/V in the context of an impaired ejection frac-
tion (45 ± 16%; p< 0.001 vs. normal group). This pattern
was termed LV decompensation and replaced eccentric
hypertrophy as the sixth pattern of LV adaption in our
classification.
There was no relationship between aortic stenosis se-
verity and the pattern of LV remodeling or hypertrophy
(P = 0.22; Table 1). Compared to normotensive patients,
those with co-existent hypertension were more likely to
have an asymmetric pattern of wall thickening (43% vs.
17%, P = 0.01) but importantly there was no difference in
the proportion of patients with LV remodeling (24% vs.
24%, P = 1.00), hypertrophy (59% vs. 48%, P = 0.39) or de-
compensation (14% vs. 9%, P = 0.73; Table 3).
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Figure 2 Lack of correlation between aortic valve area and left ventricular mass index. A. Total population. B. Population after excluding
patients with hypertension. C. Males. D. Females.
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Asymmetric versus concentric patterns of wall thickness
An asymmetric pattern of LV wall thickness was
observed in 25 patients (27%) with remodeling or hyper-
trophy (Table 4). Compared to concentric patterns,
patients were older (72 ± 11 vs. 56 ± 19 years, P< 0.001),
more likely to have hypertension (64 vs. 33%, P = 0.01)
and had a greater maximal wall thickness (17 ± 2 vs.
15 ± 3 mm, P< 0.001). The site of asymmetry was most
often in the basal septum (Figure 3) and affected two
segments of the 17-segment model in 72% of subjects
(1 segment in 24%; 3 segments in 4%). In 7%, it affected
the basal anterior wall but otherwise focal wall thickening
was not observed outwith the septum.
Table 2 Univariate analysis of the association between
the indexed left ventricular mass and different
independent variables
Variable Mean difference in
Indexed Mass (g/m2)
Confidence
Intervals
P value
Age >66 years 7.5 -3.4–18.4 0.17
Male 13.8 2.8–24.7 0.02
Moderate Aortic Stenosis 3.9 -7.6–15.5 0.50
Bicuspid -7.3 -18.4–3.9 0.20
Hypertension 9.9 -1.1–20.9 0.08
Diabetes mellitus 11.9 -3.6–27.4 0.13
ACE Inhibitor/ARB 11.2 -1.00–23.3 0.07
β-Blocker 3.2 -11.2–17.6 0.66
Male sex was the only variable associated with a significant increase in the LV
mass index, being 13.8 g/m2 higher in males than females. There was no
difference in LV mass between patients with moderate and severe aortic
stenosis.
Table 3 Comparison of the remodeling and hypertrophic
response in aortic stenosis patients with and without
concomitant hypertension
Hypertension No
Hypertension
P value
Number 37 54 -
Male Sex % 23 (62%) 34 (62%) 1.00
Age (years) 70 ± 13 55 ± 21 <0.01*
Aortic Valve Area (cm2) 1.00 ± 0.33 0.88 ± 0.31 0.09
Indexed LVEDV (ml/m2) 76 ± 24 78 ± 29 0.74
LV mass index (g/m2) 102± 28 93 ± 25 0.08
M/V (g/ml) 1.41 ± 0.37 1.27 ± 0.38 0.10
Maximal wall thickness (mm) 16 ± 3 14± 3 <0.01*
Asymmetric Wall Thickening n (%) 16 (43%) 9 (17%) 0.01*
Pattern of Remodeling/Hypertrophy
Normal n (%) 1 (3%) 10 (19%) 0.02*
Remodeling n (%) 9 (24%) 13 (24%) 1.00
Concentric n (%) 2 (5%) 9 (17%) 0.19
Asymmetric n (%) 7 (19%) 4 (7%) 0.11
Hypertrophy n (%) 22 (59%) 26 (48%) 0.39
Concentric Hypertrophy n (%) 13 (35%) 21 (39%) 0.83
Asymmetric Hypertrophy n (%) 9 (24%) 5 (9%) 0.07
LV Decompensation n (%) 5 (14) 5 (9%) 0.73
Categorical variables expressed as n (%) and compared using Fisher’s exact
test. Continuous variables expressed as the mean ± SD and compared using
the Student’s unpaired t-test. *P< 0.05.
Table 4 Comparison of patient characteristics between
those with asymmetric and concentric forms of
hypertrophy and remodeling in aortic stenosis
Concentric Asymmetric p-value
Number 45 25 -
Age (years) 56 ± 19 72 ± 11 <0.01*
Male sex (%) 62 68 0.41
LV mass index (g/m2) 103 ± 25 96 ± 25 0.23
Max wall thickness (mm) 15 ± 3 17± 2 <0.01*
Hypertrophy (%) 76 56 0.09
Aortic valve area (cm2) 0.96 ± 0.36 0.96 ± 0.30 0.83
Ejection Fraction 72 ± 12 71 ± 15 0.79
Indexed LVEDV (mL/m2) 72 ± 20 69 ± 22 0.57
Hypertension (%) 33 64 0.01*
Diabetes Mellitus (%) 11 12 0.91
ACE inhibitor/ARB use (%) 33 45 0.45
Beta-blocker (%) 16 27 0.32
Asymmetric left ventricular wall thickening was defined as a regional wall
thickening ≥13 mm that was >1.5-fold the thickness of the opposing
myocardial segment. Criteria had to be fulfilled on two adjacent short-axis
slices.
Figure 3 Site of maximal wall thickening in asymmetric
hypertrophy and remodeling based on the 17-segment model
of the left ventricle. Asymmetric wall thickening was observed in
the basal anterior wall in 7%, otherwise it was confined to the
septum at the basal and mid-cavity levels.
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Discussion
This is the first study to use CMR to investigate both
the magnitude of the hypertrophic response and the dif-
ferent morphological patterns of remodelling and hyper-
trophy observed in patients with aortic stenosis. We
have demonstrated that the degree and pattern of hyper-
trophy is independent of the severity of valve stenosis
severity. We observed six distinct patterns of left ven-
tricular adaption, which in line with previous echocar-
diographic definitions included normal left ventricular
structure, concentric remodeling, and concentric hyper-
trophy. However in contrast to previous classifications,
we also describe asymmetric remodeling and asymmetric
hypertrophy as common structural variants.
Magnitude of the hypertrophic response
The magnitude of left ventricular hypertrophy varied
widely but was unrelated to the severity of aortic sten-
osis, such that patients with severe valve narrowing were
found to have normal ventricular structure whilst
patients with moderate disease often had extensive
hypertrophy. This observation is consistent with the
findings of several previous echocardiographic studies
[18-20], but has not previously been reported using
CMR.
The apparent disconnect between processes in the
valve and myocardium might explain the marked hetero-
geneity between the severity of valve stenosis and symp-
tom onset, and is important because an advanced
hypertrophic response is associated with an adverse
prognosis in a range of cardiac conditions including aor-
tic stenosis [3-5,21]. Recent data has suggested that this
might reflect its association with mid-wall fibrosis: an in-
dependent predictor of all-cause mortality in patients
with moderate and severe disease [22]. We therefore be-
lieve that when considering overall aortic stenosis sever-
ity, attention should be paid not only to the degree of
valve narrowing but also to the hypertrophic response
accompanying it.
Consistent with previous studies, male gender was the
only variable associated with an increased left ventricular
mass [23,24] although an apparent trend was observed
with concomitant hypertension. The latter was also seen
in an analysis of the Simvastatin and Ezetimibe in Aortic
Stenosis (SEAS) trial where hypertension predicted
increased left ventricular mass in patients with aortic
stenosis independent of other known confounders [25].
Strict blood pressure control may therefore provide an
important clinical means of blunting the hypertrophic
response.
Importantly the lack of correlation between valve sten-
osis and the hypertrophic response persisted in subgroup
analyses of our male, female and normotensive patients
indicating that gender and blood pressure cannot in
themselves explain this observation. Genetic factors were
not investigated in this study and are likely to play an
important role. These are known to modulate the mag-
nitude of the hypertrophic response to a number of
physiological and pathological triggers [26-28]. These in-
clude aortic stenosis, in which polymorphisms of the
angiotensin-converting enzyme I/D genotype have been
associated with different degrees of wall thickening and
hypertrophy [23], as well as the regression of these pro-
cesses following valve replacement [29].
Asymmetric remodeling and hypertrophy
An asymmetric pattern of wall thickening was observed
in 27% of our cohort, being particularly prevalent
amongst the elderly and in those with hypertension. This
confirms the echocardiographic findings of Tuseth and
colleagues who described asymmetric wall thickening in
22% of patients with aortic stenosis, and also observed
an association with co-existent hypertension [9]. Import-
antly our study demonstrated asymmetric wall thicken-
ing in a sixth of normotensive patients with aortic
stenosis, confirming that it is not only a response related
to high blood pressure.
Asymmetric wall thickening was most frequently
observed in the septum at the basal and mid-cavity
levels with a mean of 17 mm and a maximum of
22 mm. Current guidelines recommend that a diagnosis
of hypertrophic cardiomyopathy be considered if re-
gional wall thickness exceeds 15 mm, with an intermedi-
ate area existing between 13 and 15 mm [30]. Our data
therefore suggest considerable overlap in the appear-
ances of asymmetric wall thickening in these two condi-
tions and underlines the fact that the morphological
diagnosis of hypertrophic cardiomyopathy may be chal-
lenging or impossible in the context of an increased
afterload. Furthermore it is plausible that specific geno-
types, related to those causing hypertrophic cardiomyop-
athy, may predispose to an asymmetric rather than
concentric remodeling response. In line with this theory,
patients with hypertension and asymmetric thickening
have a higher familial incidence of hypertrophic cardio-
myopathy and more myocardial disarray [31].
Left ventricular decompensation
Eccentric hypertrophy has been included in previous
definitions of remodeling and hypertrophy in aortic sten-
osis but this was not observed in our study [7]. The
strict selection criteria employed in our population ex-
cluded patients with conditions such as aortic and mitral
regurgitation and ischemic heart disease that in clinical
practice will result in a composite form of left ventricu-
lar adaption and perhaps explain the eccentric pheno-
type observed in previous cohorts. Instead we observed
a form of left ventricular decompensation characterized
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by impaired systolic function and left ventricular dilata-
tion. This form of remodeling can be considered as the
end-stage of the hypertrophic process in which the left
ventricle has failed in the face of an increased afterload.
Given that a reduction in ejection fraction is a powerful
prognostic marker in aortic stenosis, this pattern of LV
adaption is likely to be associated with an increased
mortality [32]. Interestingly not all patients with a reduc-
tion in ejection fraction conformed to this phenotype:
41% had either concentric or asymmetric hypertrophy. It
is likely that these patients are in the early stages of de-
compensation without having yet proceeded to left ven-
tricular dilatation. They represent an important group to
identify because prompt surgery might avoid a further
deterioration in ejection fraction.
Patterns of remodeling and aortic stenosis
It has been proposed that in response to an increased
afterload patients progress from a normal ventricle to
LV remodeling, and then hypertrophy before decompen-
sating and developing heart failure. However in our
study, there was no clear correlation between the sever-
ity of aortic valve narrowing and the different patterns
of LV adaption, except that all patients with LV dilatation
had severe disease. This may simply reflect the relatively
small sample size, however there are two alternative ex-
planations. Firstly patients transition through the various
stages of the remodeling process at different rates, much
in the same way that they display variation in the magni-
tude of the hypertrophic response. Secondly patients do
not in fact progress with time from LV remodeling to
hypertrophy but instead these represent two distinct and
independent pathways of adaption. Prospective longitu-
dinal studies are required to address this issue.
Study limitations
Thirty-seven patients from our cohort had co-existent
mild to moderate hypertension. Given that hypertension
and aortic stenosis commonly co-exist, it was not desir-
able to exclude all patients with hypertension from the
study, as this would have affected the generalizability of
our findings. However, sub-group analysis allowed us to
examine how co-existent hypertension might modulate
the effect of valve narrowing. This demonstrated that
hypertension was associated with an apparent increase
in the LV mass index and an increased proportion of
patients with asymmetric wall thickening. Importantly
however the lack of correlation between the LV mass
index and aortic stenosis severity remained and was in-
dependent of the effects of blood pressure.
In our institution local guidelines recommend CMR
for all patients with severe aortic stenosis. However
patients with moderate disease were referred at the dis-
cretion of their clinician and therefore there may have
been some referral bias in this group. In addition, we
have not examined patients with mild disease nor the in-
fluence of the duration of aortic stenosis. The latter is al-
most impossible to adjudicate because the majority of
patients will have subclinical disease for many years be-
fore a murmur is detected and the diagnosis established.
Multi-centre longitudinal trials are required in an un-
biased population to confirm our findings and to provide
prognostic information. In the era of transcatheter aortic
valve implantation (TAVI), where earlier treatment may
have benefit, it will also be important to assess if the dif-
ferent patterns of remodeling and hypertrophy show
variable potential for reverse remodeling following
intervention.
Conclusions
We have demonstrated marked variation in the hyper-
trophic response of the left ventricle in a selected cohort
of patients with aortic stenosis in the absence of coron-
ary artery disease, cardiomyopathy and other forms of
valve disease. The degree of the hypertrophic response
was independent of the severity of valve narrowing and
six distinct patterns of LV adaption were observed. These
included asymmetric remodeling and hypertrophy, which
displayed considerable overlap in appearances with hy-
pertrophic cardiomyopathy. This variation highlights the
importance of detailing the left ventricular remodeling
response in all patients with aortic stenosis, particularly
given the adverse prognosis associated with increased
levels of hypertrophy.
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